Gal-9 is likely upregulated early on during cross-presentation of tumor antigens when intratumoral DCs sense danger signals from dying tumor cells, but is only secreted in large quantities after T cells are activated to produce IFNγ. The gene discussed is LGALS9; the disease is neoplasm.